| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |